Abstract
OLib proposes to offer pharmaceutical standards for analytical and quantitative studies (for instance, identification and toxicological tests, among others). The company was thought aiming to answer a great need of the Brazilian pharmaceutical scenario, which needs standards to comply with the legislation (cf. stablished by ANVISA), thus offering a reliable service, with short delivery ti…